Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
198 | 3 | MYELODYSPLASTIC SYNDROME//HEMATOLOGY//ACUTE MYELOID LEUKEMIA | 52973 |
112 | 2 | MYELODYSPLASTIC SYNDROME//ACUTE MYELOID LEUKEMIA//HEMATOLOGY | 24683 |
1198 | 1 | ACUTE MYELOID LEUKEMIA//GEMTUZUMAB OZOGAMICIN//AML | 2813 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | ACUTE MYELOID LEUKEMIA | authKW | 1751168 | 30% | 19% | 845 |
2 | GEMTUZUMAB OZOGAMICIN | authKW | 760323 | 3% | 75% | 91 |
3 | AML | authKW | 470654 | 11% | 13% | 314 |
4 | ACUTE MYELOID LEUKAEMIA | authKW | 459299 | 6% | 23% | 179 |
5 | CYTARABINE | authKW | 200185 | 3% | 18% | 98 |
6 | VOSAROXIN | authKW | 179855 | 1% | 94% | 17 |
7 | MONOSOMAL KARYOTYPE | authKW | 144530 | 1% | 65% | 20 |
8 | HEMATOLOGY | WoSSC | 129675 | 65% | 1% | 1818 |
9 | MYLOTARG | authKW | 129486 | 1% | 68% | 17 |
10 | POSTREMISSION THERAPY | authKW | 118924 | 1% | 56% | 19 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Hematology | 129675 | 65% | 1% | 1818 |
2 | Oncology | 24791 | 49% | 0% | 1372 |
3 | Transplantation | 1950 | 6% | 0% | 163 |
4 | Immunology | 203 | 6% | 0% | 167 |
5 | Medicine, General & Internal | 98 | 5% | 0% | 127 |
6 | Pediatrics | 55 | 3% | 0% | 73 |
7 | Geriatrics & Gerontology | 27 | 1% | 0% | 23 |
8 | Medicine, Research & Experimental | 22 | 2% | 0% | 66 |
9 | Medical Laboratory Technology | 21 | 1% | 0% | 20 |
10 | Education, Scientific Disciplines | 20 | 1% | 0% | 18 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | HEMATOL | 101071 | 24% | 1% | 686 |
2 | LEUKEMIA | 76433 | 5% | 5% | 133 |
3 | LEUKEMIA DIAGNOST | 51161 | 1% | 24% | 19 |
4 | STEM CELL TRANSPLANTAT UNIT | 49150 | 1% | 16% | 27 |
5 | OR LEUKAMIEDIAGNOST | 40005 | 0% | 71% | 5 |
6 | MYELOID MALIGNANCIES SECT | 36656 | 0% | 55% | 6 |
7 | ZENTRUM BLUTSTAMMZELL KNOCHENMARKTRANSPLANTAT | 35845 | 0% | 80% | 4 |
8 | AML BFM STUDY GRP | 35837 | 0% | 40% | 8 |
9 | HEMATOL L413 | 33606 | 0% | 100% | 3 |
10 | CLIN CANC IMMUNOL TRIALS | 29870 | 0% | 67% | 4 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | LEUKEMIA | 62204 | 7% | 3% | 207 |
2 | LEUKEMIA RESEARCH | 36795 | 5% | 2% | 142 |
3 | BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY | 31292 | 2% | 6% | 49 |
4 | LEUKEMIA & LYMPHOMA | 25464 | 5% | 2% | 133 |
5 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 19162 | 1% | 5% | 38 |
6 | BRITISH JOURNAL OF HAEMATOLOGY | 18789 | 5% | 1% | 152 |
7 | BLOOD | 18053 | 8% | 1% | 238 |
8 | ANNALS OF HEMATOLOGY | 17906 | 3% | 2% | 78 |
9 | JOURNAL OF CLINICAL ONCOLOGY | 14554 | 5% | 1% | 147 |
10 | CURRENT OPINION IN HEMATOLOGY | 14195 | 1% | 3% | 39 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ACUTE MYELOID LEUKEMIA | 1751168 | 30% | 19% | 845 | Search ACUTE+MYELOID+LEUKEMIA | Search ACUTE+MYELOID+LEUKEMIA |
2 | GEMTUZUMAB OZOGAMICIN | 760323 | 3% | 75% | 91 | Search GEMTUZUMAB+OZOGAMICIN | Search GEMTUZUMAB+OZOGAMICIN |
3 | AML | 470654 | 11% | 13% | 314 | Search AML | Search AML |
4 | ACUTE MYELOID LEUKAEMIA | 459299 | 6% | 23% | 179 | Search ACUTE+MYELOID+LEUKAEMIA | Search ACUTE+MYELOID+LEUKAEMIA |
5 | CYTARABINE | 200185 | 3% | 18% | 98 | Search CYTARABINE | Search CYTARABINE |
6 | VOSAROXIN | 179855 | 1% | 94% | 17 | Search VOSAROXIN | Search VOSAROXIN |
7 | MONOSOMAL KARYOTYPE | 144530 | 1% | 65% | 20 | Search MONOSOMAL+KARYOTYPE | Search MONOSOMAL+KARYOTYPE |
8 | MYLOTARG | 129486 | 1% | 68% | 17 | Search MYLOTARG | Search MYLOTARG |
9 | POSTREMISSION THERAPY | 118924 | 1% | 56% | 19 | Search POSTREMISSION+THERAPY | Search POSTREMISSION+THERAPY |
10 | MINIMAL RESIDUAL DISEASE | 114756 | 4% | 9% | 120 | Search MINIMAL+RESIDUAL+DISEASE | Search MINIMAL+RESIDUAL+DISEASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |